Navigation Links
Bellicum Pharmaceuticals Raises $34.4 Million in a Series B Financing
Date:1/7/2014

HOUSTON, Jan. 7, 2014 /PRNewswire/ -- Bellicum Pharmaceuticals, Inc. announced today that it has completed a second and final closing of its Series B financing, securing an additional $14.7 million and bringing the total raised in the round to $34.4 million. Current investors provided the additional funding, including AVG Ventures and Remeditex Ventures.

The funding will be used to expand clinical development of Bellicum's lead cellular immunotherapy product candidates.

"Bellicum is well positioned within the highly promising field of cellular immunotherapy with a technology that provides control over cells after they have been administered to the patient," said Bellicum CEO Tom Farrell. "This funding will be used to advance our two clinical programs in leukemia/lymphoma and prostate cancer, and launch studies in additional indications where there is urgent need for safer and more effective cell therapies."

Bellicum's two lead clinical development programs utilize the Company's unique ability to control cell therapies once inside the body. BPX-501 T cells contain the Company's CaspaCIDe™ gene "safety switch," enabling physicians to eliminate transplanted cells in the event they become harmful to the patient. The product is being evaluated in a Phase I/II study to reduce or eliminate Graft versus Host Disease in cancer patients undergoing hematopoietic stem cell transplant.

BPX-201 dendritic cells contain the Company's DeCIDe® gene "on switch," which enables physicians to strategically target immune activation for a more potent anti-tumor effect. It is being evaluated in a Phase I clinical trial in patients with metastatic castrate-resistant prostate cancer.

About Bellicum Pharmaceuticals

Bellicum is dedicated to developing safer and more effective cell therapies to treat cancers and other serious, life-threatening diseases. The Company's cel
'/>"/>

SOURCE Bellicum Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 13
2. Avanir Pharmaceuticals to Present at J.P. Morgan 32nd Annual Healthcare Conference
3. ANI Pharmaceuticals Enters Development Agreement for Generic Drug Product with Sterling Pharmaceutical Services
4. Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
5. Isis Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
6. Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference
7. Global Radiopharmaceuticals Market Report 2013 - 2018
8. Pre-Market Update: MGT Capital Investments, National American University Holdings and Actinium Pharmaceuticals
9. ANI Pharmaceuticals Acquires 31 Generic Drug Products from Teva Pharmaceuticals
10. New Appointments, and Share Price Movements - Research Report on Humana, Illumina, Edwards Lifesciences, Aegerion Pharmaceuticals, and CytRx
11. Taiwan Spends a High Percentage of its Healthcare Budget on Pharmaceuticals, but Second Generation Healthcare Reform is Transforming the Market Landscape
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 6, 2015  Law office of Brodsky & ... claims against the Board of Directors of Pharmacylics, ... breaches of fiduciary duty and other violations of ... the Company to AbbVie, Inc. ("AbbVie") ... http://brodsky-smith.com/900-pcyc-pharmacyclics-inc.html , or call: 877-534-2590. There is ...
(Date:3/6/2015)... LAKE FOREST, Ill. , March 6, 2015   ... and the U.S. Food and Drug Administration (FDA) on today,s ... United States . This is a watershed moment for ... medicines. As a leading global provider of biosimilars, Hospira has ... and we are a proud participant in these early stages ...
(Date:3/6/2015)... 6, 2015  Abaxis, Inc. (NasdaqGS: ABAX ... consumables for the medical, research, and veterinary markets worldwide ... research markets in the United States ... of the U.S. Department of Agriculture (USDA) has cleared ... of   A. phagocytophelium and A. platys ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Pharmacyclics, Inc. - PCYC 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Abaxis, Inc. Announces USDA Clearance of VetScan Anaplasma Rapid Test 2Abaxis, Inc. Announces USDA Clearance of VetScan Anaplasma Rapid Test 3
... SALT LAKE CITY, Feb. 28, 2011 Concentra, a ... is transforming the future of occupational and urgent care ... and engaging experiences for clients and patients. Recent customer ... the ranks of top U.S. consumer companies as a ...
... 2011 caprotec bioanalytics GmbH announced today ... of three core patents protecting its proprietary and revolutionary ... CCMS offers a novel and direct way to investigate ... functional reduction of proteome complexity. The core of the ...
Cached Medicine Technology:Concentra is Writing a New Prescription on Health Care With Outstanding Service 2Concentra is Writing a New Prescription on Health Care With Outstanding Service 3Concentra is Writing a New Prescription on Health Care With Outstanding Service 4Concentra is Writing a New Prescription on Health Care With Outstanding Service 5caprotec bioanalytics Announces Issuance In Europe of All Core Patents of Its CCMS Technology 2
(Date:3/6/2015)... Ticket Down is a reliable source for authentic ... California. This state-of-the-art stadium opened on July 17, 2014 ... , The “Kick the Dust Up Tour” featuring country megastar ... west coast and Levi’s Stadium. The show at the new ... 29 and fans of the award-winning artist will be able ...
(Date:3/6/2015)... 06, 2015 Ticket Down is a reputable ... at the Moda Center. After being away from ... is showing no signs of letting up on his “Garth ... and his wife, Trisha Yearwood, to venues around the United ... their critically acclaimed tour to the Moda Center in Portland, ...
(Date:3/6/2015)... Jose, California (PRWEB) March 06, 2015 ... and implants such as bridges and crowns, abutments and ... from conditions caused by decayed teeth and missing teeth. ... and implant consumables is driven by an aging global ... technologies. With about 4%-5% of the 65+ population being ...
(Date:3/6/2015)... New York (PRWEB) March 06, 2015 “On ... dazzling days on the grand stage, to the silver screen ... sparkle throughout with precision toe-tapping numbers and their famous eye-high ... Tomczak deliver the rich history of tap dancing in this ... to come out of the United States. , “On ...
(Date:3/6/2015)... 06, 2015 Further solidifying their position ... Doctor Associates announced today that the company has earned ... the Best of Staffing Talent Award five years in ... of Staffing Talent Diamond winners are proven industry leaders ... them by the individuals they have helped find temporary ...
Breaking Medicine News(10 mins):Health News:Cheap Luke Bryan Tickets at Levi's® Stadium in Santa Clara, CA: Ticket Down Slashes Ticket Prices on Luke Bryan Concert Tickets in Santa Clara at the New Levi's® Stadium 2Health News:Cheap Luke Bryan Tickets at Levi's® Stadium in Santa Clara, CA: Ticket Down Slashes Ticket Prices on Luke Bryan Concert Tickets in Santa Clara at the New Levi's® Stadium 3Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:Aging Population & Emphasis on Dental Care Drives the Dental Prosthetic & Implant Consumables Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population & Emphasis on Dental Care Drives the Dental Prosthetic & Implant Consumables Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 3
... early in life. ,Dr. Martha Terris, urologist at ... according to the study it was found that several younger ... marijuana smoking. ,She conducted her study on 52 ... cancer. She found that about 88.5% of them had a ...
... and a closely monitored surveillance for patients with colon ... of cancer recurrence // compared to less aggressive strategy ... Researchers have found that an intensified follow up of ... of early diagnosis of cancer recurrence which could help ...
... are finding out the mechanism behind bacterial resistance from ... bacterial infection. // The researchers are using this mice ... help in treating bacterial infections. ,Bacterial infections ... all age groups mostly affecting the immune compromised. There ...
... gigantic proportions not only in the animal world but human world ... to visit // countries with bird flu like China, Vietnam, Turkey ... the unanimous voice is to take the plunge as bird flu ... worry., ,The infection in humans is due to close proximity ...
... The bird flu scare is not discouraging people from Hong Kong ... traditional dish consumed during the // ar New Year holiday. One ... residents would ask vendors to kill and pluck the birds to ... ,Hong Kong health authorities have already announced that a family of ...
... to cough up more towards health benefits for their workers ... for the needy, according to the recent communiqué. A bill ... ,Wal-Mart, the retail giant, was recently subjected to a ... turn of the California laws intended for employers with a ...
Cached Medicine News:
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Steroid-eluting, screw-in pacing lead...
Medicine Products: